dobutamine has been researched along with Bladder Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronsson, P; Carlsson, T; Patel, B; Vesela, R; Winder, M | 1 |
1 other study(ies) available for dobutamine and Bladder Cancer
| Article | Year |
|---|---|
Autonomic Receptor-mediated Regulation of Production and Release of Nitric Oxide in Normal and Malignant Human Urothelial Cells.
Topics: Adrenergic beta-Agonists; Cell Line, Tumor; Dobutamine; Humans; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Receptors, Adrenergic, beta; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2017 |